Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Epilepsy
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Epilepsy
    TopAbstracts in Epilepsy 06/25/2009 - (DGNews)
    TopAbstracts in Epilepsy 06/11/2009 - (DGNews)
    FDA Approves Once-Daily Extended Release Lamotrigine for Epilepsy - (DGNews)
    TopAbstracts in Epilepsy 05/28/2009 - (DGNews)
    TopAbstracts in Epilepsy 05/14/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Epilepsy
  • Some Anti-Epileptic Drugs May Compromise Bone Health
  • Balancing Treatment With Reproductive Health in Women With Epilepsy
  • Understanding the Ramifications of Switching Among AED's: A 2008 Clinical Update

    Webcasts/CME archive

     Recent cases - Epilepsy
      Diarrhea, Negative T-Waves, Fever and Skin Rash, Rare Manifestation of Carbamazepine Hypersensitivity: A Case Report
      Syncope Due to Asystole During Epilepsy. A Case Report
      Lennox Gastaut Syndrome, Review of the Literature and a Case Report
      Partial Trisomy 13q22-qter Associated to Leukoencephalopathy and Late Onset Generalised Epilepsy
      Probable Causal Link Between Epilepsy and Sleep Apnea: Case Report

      Cases archive
        




      my personal edition > epilepsy > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Clinical Signs Of Hyperandrogenism With Valproate More Common In Epilepsy Patients Than Bipolar Patients

      A DGReview of :"Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women?"
      Progress in Neuro-Psychopharmacology & Biological Psychiatry

      02/10/2003
      By Alison Palkhivala


      Valproate therapy may cause menstrual abnormalities and increased total serum testosterone levels in women with epilepsy or bipolar disorder.

      Women with bipolar disorder taking the drug were, however, found to be less likely than those with epilepsy to have clinical features of hyperandrogenism.

      Thirty women, aged 18 to 40, with a diagnosis of bipolar disorder based on Diagnostic and Statistical Manual of Mental Disorders (DSM)-IV criteria, and 15 women with idiopathic generalized epilepsy were evaluated for reproductive and endocrine functioning and metabolic parameters. Among the women with bipolar disorder, 15 were on lithium monotherapy and 15 were on valproate monotherapy or valproate combined with lithium therapy. All the women with epilepsy were on valproate monotherapy. The study was conducted by F. Akdeniz and colleagues from the department of psychiatry, Affective Disorders Unit, Ege University School of Medicine, Izmir, Turkey.

      The two groups of women were similar with respect to menarche age, mean length of menstrual cycle and mean length of menses. However, three of the bipolar patients taking valproate and seven of the epileptic patients taking this drug reported menstrual difficulties. None of the patients with bipolar disorder taking lithium monotherapy reported such problems.

      Epilepsy patients had higher hirsutism scores than did bipolar patients, regardless of the therapy they were taking. Serum total testosterone levels were higher among those taking valproate, compared with lithium, regardless of the condition it was being taken to treat. Serum follicle stimulating hormone (FSH) levels were significantly lower and luteinizing hormone (LH)-to-FSH ratios were significantly higher in patients with epilepsy than those with bipolar disorder, regardless of the treatment they were receiving. Weight parameters and lipid values were similar between the two groups of women.
      Prog Neuropsychopharmacol Biol Psychiatry 2003 Feb;27:1:115-21. "Valproate-associated reproductive and metabolic abnormalities: are epileptic women at greater risk than bipolar women?"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send